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Abstract
Klinefelter syndrome (KS) (47, XXY) is the most common sex chromosome disorder, with a
prevalence of 1 in every 660 newborn males. Despite the profound adverse effects of anxi-
ety and depression, and their greater prevalence in KS populations, no research has been
conducted to date to identify the determinants of anxiety and depression among patients
with KS. We examined the relationships between personality traits, social engagement, and
anxiety and depression symptoms among KS patients (n = 69) and a group of male controls
(n = 69) matched for age and years of education. KS patients experienced more anxiety and
depression symptoms than control participants. Neuroticism was the strongest and most
consistent mediator between KS and both anxiety and depression symptoms. This research
suggests that neuroticism may play a central role in attention switching, anxiety and depres-
sion among patients with Klinefelter syndrome. The central role of neuroticism suggests that
it may be used to help identify and treat KS patients at particularly high-risk for attention-
switching deficits, anxiety and depression.
Introduction
Klinefelter syndrome (KS) (47, XXY) is the most common sex chromosome disorder, with a
prevalence of 1 in every 660 newborn males [1;2]. KS is associated with a wide spectrum of
comorbidities, including an increased risk of a broad range of mental disorders [3–5]. KS
patients are more than three times more likely than the general population to be hospitalized
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with a psychiatric disorder, with a hazard ratio of 3.65 [6]. Two of the most prevalent and
debilitating affective symptoms among KS patients are anxiety and depression. Approximately
18% of KS [4] suffer from generalized anxiety. In addition, rates of clinical depression among
KS range from 19 to 24% [3;4], with more than two-thirds (68%) of KS patients reporting
depressive symptoms[7]. However, despite the profound adverse effects of anxiety and depres-
sion, as well as their greater prevalence in KS populations, no research has been conducted to
date to identify the predictors of anxiety and depression among patients with KS. Learning
about these associations is important for a better understanding of KS patients’ mental health,
as well as for improving the effectiveness of interventions to reduce anxiety and depression
among those with KS [8].
Personality traits represent an important group of potential predictors of KS patients’ anxi-
ety and/or depression, as they develop early in life, they are stable over time, and they have
been linked to various forms of psychopathology [9–14]. Increased neuroticism in the general
population is associated with generalized anxiety disorder (GAD) and major depressive disor-
der (MDD), while conscientiousness and extraversion are both negatively correlated with both
GAD and MDD (although the link between extraversion and MDD is less consistent) [13]. In
other studies, personality traits have been used to identify individuals at risk for onset of men-
tal illness [15–17], supporting the vulnerability model of psychopathology, which hypothesizes
that personality traits contribute significantly to the development of psychiatric disorders
[18;19]. Previously, we showed that KS is associated with higher levels of neuroticism and
lower levels of extraversion, conscientiousness, and openness to experience [20]. However, the
question of whether these KS personality profiles make KS patients more vulnerable to psycho-
pathology–particularly anxiety and depression–has yet to be addressed.
In addition to personality traits, social engagement has also been proposed as an important
factor in relation to psychopathology [21–24]. Social engagement reflects an individual’s gen-
eral social skills and experiences, including interpersonal attention and communication. The
relationship between social skills and interpersonal relations have been well-documented
[25;26], as has the link between interpersonal relations and psychopathology [27–30]. More-
over, positive relations with others have been found to mediate the association between social
skills and psychopathology [22]. Deficits in social engagement is characteristic of patients with
KS, including deficits in attention switching, imagination, communication and general social
skills[20;31], which may help explain KS patients’ increased risk of mental illness in general,
and anxiety and depression in particular.
To address these issues, we examined the relationships between personality traits, social
engagement, and anxiety & depression symptoms among KS patients and a group of male con-
trols matched for age and years of education. Both zero-order and path analyses were per-
formed to identify direct and indirect relationships between these study variables.
Materials and methods
Participants
Patients with verified KS were recruited from endocrinology, genetics and fertility clinics in
Denmark. Participants included 69 KS patients with 47,XXY karyotype, with a mean age of
36.4 years (SD = 10.0), and an average of 12.6 years (SD = 2.35) of formal education. At the
time of participation, 48 (70%) of the patients with KS were receiving testosterone, and 21
(30%) were not. Fourteen of these 21 KS patients had never received testosterone treatment,
while 6 had been treated with testosterone in the past (ranging from 6 month-7.3 years, with
an average of 32.5 months). One patient with KS reported being treated with testosterone for
an unspecified period in the past.
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In addition, 69 matched male controls—with a mean age of 36.4 years (SD = 9.6) and an aver-
age of 12.8 years (SD = 2.21) of formal education—were recruited through advertisement in local
hospitals, newspapers, fire departments, and other civil service offices. There were no significant
differences between KS and control participants in either age or education level (ps>.84). Inclu-
sion criteria required that participants be between the ages of 18 and 60, and exclusion criteria
included a history of substance use, and neurological disease or head injury more severe than sim-
ple concussion. All participants received oral and written information about the requirements of
the study before written consent was obtained, and informed consent was obtained before partici-
pation was initiated. The study was approved by The Danish Data Protection Agency and local
ethics committee (Region Midtjylland, Denmark number M-20080238) and registered at Clinical-
Trials.gov (Clinical trial NCT00999310). Certain neuropsychological data from this research has
been presented previously to address separate research questions [20;32;33].
Measures
Personality. Personality traits were assessed using the Revised NEO Personality Inventory
(NEO PI-R) short form[34]. This form includes measures of neuroticism (12 items), extraver-
sion (12 items), agreeableness (12 items), conscientiousness (12 items), and openness to expe-
rience (12 items). For all items, participants indicated how well each statement described them
on a scale form 1 (“very inaccurate”) to 5 (“very accurate”). Items responses within each per-
sonality measure were combined to create five personality scores for each participant. Cron-
bach´s alphas for these personality traits range from 0.70–0.90.
Social engagement. Social engagement was assessed using the Autism Spectrum Quotient
(AQ) [35]. This questionnaire includes measures of attention to detail (10 items), attention
switching (10 items), imagination (10 items), communication (10 items), and general social
skills (10 items). For all items, participants indicated how well each statement described them
on a scale from 1 (“definitely disagree”) to 4 (“definitely agree”). Negative worded items were
reverse coded, so that higher scores for each item reflected more of each social engagement
measure. Item responses within each measure were then combined to create five social engage-
ment scores for each participant. Cronbach´s alphas in the current study for these social
engagement measures ranged from 0.61 to 0.74.
Anxiety and depression. Symptoms of anxiety and depression were assessed using the
anxiety (SLC-ANX) and depression (SLC-DEP) subscales of the Symptom Checklist (SLC-90)
[36;37]. The SCL-ANX subscale is composed of the four items (i.e., “worrying too much”;”sud-
denly scared for no reason”; “nervousness or shakiness inside”; and “panic”), while the
SCL-DEP is composed of six items (i.e., “feeling sad”; “feeling worthless”; “blaming yourself
for things”; “feeling lonely”; “a feeling of being trapped”; and “suicidal thoughts”). Participants
indicated how well each statement described them on a scale from 0 (“Not at all”) to 4 (“very
much”). Item responses within the SCL-ANX were combined to create an overall anxiety-
symptom score, and responses within the SLC-DEP were combined to create an overall
depression-symptom score for each participant. Cronbach´s alphas for the SCL-ANX and
SCL-DEP were 0.80 and 0.85, respectively.
Testosterone. Testosterone levels for all participants were measured by liquid chromatog-
raphy tandem mass spectrometry, using Perkin Elmer´s CHS steroid MS kit. The lower limit
of detection was 0.1nmol/L and the working range 0.2-100nmol/L.
Analyses
In preliminary analyses, KS patients were first compared with controls in terms of testoster-
one, personality, social engagement, and anxiety and depression symptoms. Bivariate
Anxiety and depression in Klinefelter syndrome
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relationships were then calculated between the continuous study measures. In the primary
analyses, two sets of three regressions—one set for anxiety, and one for depression—were con-
ducted in which each of these two dependent measures (anxiety and depression) was regressed
simultaneously on 1) personality traits, 2) social engagement measures, and 3) testosterone sta-
tus, while controlling for KS status. Finally, a path analysis was conducted which included
both anxiety and depression, as well as their respective bivariate predictors. Because path anal-
ysis is the functional equivalent of a series of multiple regressions in which each variable in the
model is successively regressed on the other variables, it controls for multicollinearity and
indicates the independent relationship between each of the factors in the model. As with the
preceding regression analyses, variables in the path model were entered simultaneously—
rather than hierarchically—and statistically significant relationships were included in the final
path model, while non-significant associations were not.
Continuous data were tested for normality using Kolmogorov-Smirnov test, and those with
distributions of Dα> 0.23 were considered non-normal, and were normalized using a log-
linear (ln+1) transformation. Differences between groups were analyzed with parametric Stu-
dent´s t-test for normally distributed data. Otherwise, data were analyzed using the Mann–
Whitney–Wilcoxon test. Chi-Square tests were used for nominal variables. P-values lower
than 0.05 were considered significant. SPSS version 19.0 (SPSS Inc., Chicago, Ill., USA) was
used for statistical data analysis.
Results
Bivariate analyses
KS vs. controls. KS patients exhibited significantly higher neuroticism than controls, as
well as significantly lower extraversion, openness to experience, and conscientiousness
(Table 1). KS and controls did not differ in agreeableness. No differences were seen between
KS patients treated with testosterone and untreated KS patients.
KS patients scored significantly lower than controls on attention switching, imagination,
communication, and social skills. However, KS patients and controls did not differ in atten-
tion-to-detail, nor did KS patients treated with testosterone differ in social engagement from
untreated KS patients.
KS patients reported significantly more anxiety and depression symptoms than controls,
although there were no differences between KS patients treated with testosterone and those
who were not.
KS patients had a significantly higher levels of testosterone than controls, reflecting the fact
that the majority of these KS participants were receiving high doses of exogenous testosterone.
Similarly, testosterone levels among KS patients receiving testosterone therapy were signifi-
cantly higher than those not receiving this therapy.
Associations between non-KS variables. In addition to being related with each other, less
neuroticism and more extraversion, conscientiousness, communication, attention switching
and social skills were all associated with fewer anxiety and depression symptoms (Table 2). No
significant differences were found between KS and controls in terms of either agreeableness or
attention to detail (ps >.33). In addition, neither openness to experience nor imagination were
associated with symptoms of anxiety or depression. Thus, these five variables were not
included in subsequent multivariate analyses.
Multivariate analyses
Multiple regressions. When KS status and personality measures (i.e., neuroticism, extra-
version, and conscientiousness) were combined to predict anxiety symptoms, the overall
Anxiety and depression in Klinefelter syndrome
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model was significant (R2 = .30, p<0.001), but neuroticism was the only significant individual
predictor (Table 3). When anxiety was regressed on KS status and social engagement (i.e.,
social skills, communication and attention switching), the full model was again significant
(R2 = .23, p< .001), with both KS status and attention switching emerging as significant pre-
dictors (ps<0.05). When KS status and testosterone levels were combined to predict anxiety,
the full model was again significant (R2 = .09, p< .01), but this was attributable solely to the
impact of KS status.
Table 1. KS patients vs. controls in terms of testosterone levels, personality, social engagement, anxiety and depression.
KS Controls
N 69 69
Mean(SD) Mean(SD) p value Cohen´s d
Testosterone (nmol/L) 17.4(11.2) 14.2(5.82) 0.04 0.36
Personality
Neuroticism a4.13(0.15) a3.90(0.24) <0.001 1.15
Extraversion a3.73(0.31) a3.95(0.29) <0.001 0.73
Openness a3.89(0.23) a4.01(0.17) 0.001 0.60
Agreeableness a3.91(0.21) a3.87(0.23) 0.33 0.18
Conscientiousness a3.81(0.25) a3.91(0.25) 0.01 0.40
Social Engagement
Attention to detail a1.82(0.35) a1.84(0.34) 0.75 0.06
Attention switching a1.78(0.45) a2.01(0.33) 0.001 0.58
Imagination a1.82(0.39) a2.04(0.28) <0.001 0.65
Communication skills a2.05(0.34) a2.17(0.22) 0.01 0.42
Social skills a1.95(0.41) a2.14(0.31) 0.003 0.52
Anxiety
Scl-anx a1.29/1.39(0.73) a0.90/1.10(0.62) 0.01 0.58
Depression
Scl-dep a1.30/1.39(0.93) a0.85/0.69(0.83) 0.03 0.51
aLn+1 transformed data
https://doi.org/10.1371/journal.pone.0206932.t001
Table 2. Correlations between testosterone, personality traits, social engagement skills, anxiety and depression.
Testosterone Personality Social engagement
Neuroticism Extraversion Openness Conscientiousness Attention
switching
Imagination Communication Social
skills
Social Engagement
Attention
switching
-0.239�� -0.519�� 0.465�� 0.246�� 0.330��
Imagination 0.083 -0.169� 0.321�� 0.421�� 0.067
Communication -0.145 -0.407�� 0.481�� 0.405�� 0.336��
Social skills -0.125 -0.504�� 0.714�� 0.336�� 0.316��
Overall score -0.219� -0.494�� 0.657�� 0.400�� -0.381��
Depression
Scl-dep 0.127 0.640�� -0.339�� -0.071 -0.444�� -0.439�� -0.040 -0.298�� -0.323��
Anxiety
Scl-anx 0.195� 0.554�� -0.283� -0.022 -0.281�� -0.449�� -0.124 -0.259�� -0.257��
�p<0.05
��p<0.01.
https://doi.org/10.1371/journal.pone.0206932.t002
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As shown in Table 4, KS status and personality measures (i.e., neuroticism, extraversion,
and conscientiousness) combined to significantly predict depression symptoms (R2 = .36, p<
.001), with neuroticism emerging as the lone significant predictor (p<0.001). Depression was
also predicted by KS status and social engagement (i.e., social skills, communication, attention
switching) (R2 = .22, p< .001), with attention switching as the significant predictor (p< .001).
When combining KS status and testosterone status, the overall model was significant (R2 = .06,
p = .014), but this was attributable to the impact of KS status (p = .01).
Path analysis. When the significant personality and social-engagement predictors were
combined with both anxiety and depression symptoms in an overall path analysis, neuroticism
fully mediated the impact of KS status on both anxiety and depression (ps < .05), as seen in
Table 3. Regression models predicting anxiety.
Independent variables Standardized β coefficient t-score p-value
Personality
KS Status 0.01 0.12 0.91
Neuroticism 0.52 4.93 <0.001
Extraversion -0.04 -0.42 0.67
Conscientiousness -0.01 -0.11 0.91
Overall model F(4,137) = 14.35, p<0.001, R2 = 0.30
Social Engagement
KS Status 0.18 2.25 0.03
Social skills 0.05 0.50 0.62
Communication -0.08 -0.81 0.42
Attention switching -0.38 -4.00 <0.001
Overall model F(4,136) = 9.64, p<0.001, R2 = 0.23
Testosterone
KS Status 0.30 3.33 0.001
Testosterone status 0.03 0.32 0.75
Overall model F(2,137) = 6.26, p = 0.003., R2 = 0.09
https://doi.org/10.1371/journal.pone.0206932.t003
Table 4. Regression models predicting depression.
Independent variables Standardized β coefficient t-score p-value
Personality
KS Status -0.08 -0.91 0.36
Neuroticism 0.55 5.41 <0.001
Extraversion -0.08 -0.92 0.36
Conscientiousness -0.05 -0.59 0.55
Overall model F(4,136) = 18.12, p<0.001, R2 = 0.36
Social Engagement
KS Status 0.12 1.41 0.16
Social skills -0.02 -0.22 0.83
Communication -0.08 -0.84 0.40
Attention switching -0.36 -3.83 <0.001
Overall model F(4,135) = 9.29, p<0.001, R2 = 0.22
Testosterone
KS Status 0.24 2.56 0.01
Testosterone status -0.03 -0.31 0.76
Overall model F(2,136) = 4.44, p = 0.014, R2 = 0.06
https://doi.org/10.1371/journal.pone.0206932.t004
Anxiety and depression in Klinefelter syndrome
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Fig 1. Neuroticism also mediated the effect of KS status on attention switching (ps < .01),
which was not directly related to either anxiety or depression symptoms. The p-values of the
non-significant associations ranged from .169 to .950.
Discussion
This research examined the influence of personality, social engagement and testosterone treat-
ment on anxiety and depression levels among KS patients. Although many of these measures
were significant bivariate predictors of anxiety and depression symptoms, subsequent regres-
sions indicated that only neuroticism and attention switching helped to explain the effect of
KS on these indices of mental health. Finally, a combined path analysis found that KS
increased both anxiety and depression symptoms through greater neuroticism.
These results are consistent with previous studies that have found more anxiety and depres-
sive symptoms among patients with KS [3;4;7], but this is the first study to assess the possible
underlying mechanism for these effects. Further, these findings indicate that, among the cur-
rent study variables, neuroticism is the strongest (and only significant) mediating link between
KS and both anxiety and depression. Neuroticism has also been found to be the strongest per-
sonality predictor of anxiety and depression in the general population [38–40], including the
onset and developmental course of both anxiety-related attention deficit disorder and major
depressive disorder [41–43]. Taken together, these results suggest that neuroticism has an
impact across populations and levels of anxiety and depression.
In this research, higher levels of neuroticism also mediated KS patients’ deficits in attention
switching. Attention switching is related to control processes of cognition such as perception,
initiation, inhibition, and executive function[44;45]. As such, it is integral to the successful per-
formance of activities involving multiple cognitive inputs, including decision-making, physical
activity and social engagement, all of which have significant implications for personal, social
and professional well-being. Although associated at the bivariate and regression analyses,
attention switching was not related to anxiety or depression in the current path analysis. It
could be that be that the earlier links between attention switching and anxiety and depression
are attributable to other factors—most notably, neuroticism. Alternatively, it is possible that,
with a larger sample size, these and other paths—both direct and indirect—may emerge.
The current results also have a number of practical implications for interventions to
improve the well-being of individuals with KS. First, the central role of neuroticism suggests
that it may be useful as a marker to identify KS patients at particularly high-risk for anxiety,
depression and attention-switching problems, who would benefit most from assistance in
these areas. A second possibility is suggested by studies finding that neuroticism levels can be
Fig 1. Path models of memory anxiety and depression with β standard coefficients and p-values.
https://doi.org/10.1371/journal.pone.0206932.g001
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raised or lowered through experience and/or training [46]. These results suggest that although
neuroticism is developed early and is generally stable over time, it may nonetheless be mutable.
If so, it may also be possible to improve mental health and other outcomes among KS patients
(and perhaps the broader population) by reducing the neuroticism that influences them.
We did not find any influence of testosterone treatment on anxiety and depression levels
among KS patients, which is in contrast with meta-analyses showing a positive impact of tes-
tosterone treatment on depressive symptoms in non-KS hypogonadal men from the general
population [47–49]. The reason for this ´missing´ effect of testosterone treatment in KS seen
in our study is not clear. Further prospective and longitudinal research is needed to address
the influence of both hypogonadism and testosterone therapy on anxiety and depression
among KS.
The limitations of this study include the cross-sectional nature of the research design.
Although it takes advantage of the early development of personality—and even earlier onset of
KS—it cannot determine the directionality or causal relationships between the study variables.
Future longitudinal and experimental research will be useful to confirm the directionality of
these effects, as well as their effectiveness in enhancing the well-being of KS patients, and per-
haps other at-risk populations.
Another limitation of this study is that we did not assess socioeconomic variables. KS is
associated with lower socioeconomic status—including lower educational and income, earlier
retirement and fewer partnerships [50]—which in turn is related to higher levels of mental ill-
ness, including anxiety and depression [51;52]. Other socioeconomic-related factors that may
also impact mental health—and help explain KS-related deficits—include low self-esteem,
social support and psychological stress[53; 54]. Future research incorporating these factors
among KS patients may further illuminate the mechanism for the increased prevalence of anxi-
ety and depression among these patients.
As the first study to assess the influence of personality traits and social engagement on anxi-
ety and depression among KS patients, this research suggests that personality, particularly neu-
roticism, plays a central role in attention switching and both measures of mental health.
Future studies with larger sample sizes, longitudinal and experimental designs, and additional
factors may help address many of the remaining questions, and further our understanding of
KS-related deficits, and in turn, improve these and other important health outcomes.
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